Biomarin Pharmaceuticals (NQ: BMRN )
116.98
+0.95
(+0.82%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 26, 2023
Add to My Watchlist
Price and Volume
Detailed QuoteVolume | 1,346,680 |
Open | 116.00 |
Bid (Size) | 116.13 (1) |
Ask (Size) | 117.27 (1) |
Prev. Close | 116.03 |
Today's Range | 115.03 - 117.11 |
52wk Range | 70.73 - 117.11 |
Shares Outstanding | 183,352,255 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Vertex Pharmaceuticals Stock Sees Rising Relative Strength
January 11, 2023
6 Analysts Have This to Say About Biomarin Pharmaceutical
January 11, 2023
2 Top Biotech Stocks Defying the Bear Market
January 10, 2023
Top Picks For 2023: Catalyst Pharmaceuticals
January 02, 2023
Expert Ratings for Biomarin Pharmaceutical
November 29, 2022
Expert Ratings for Biomarin Pharmaceutical
October 31, 2022
Why BioMarin Pharmaceuticals Fell 6.9% on Thursday
October 27, 2022
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 01, 2022
10 Health Care Stocks Whale Activity In Today's Session
November 29, 2022
Expert Ratings for Biomarin Pharmaceutical
October 13, 2022
BioMarin Lays Off 4% Of Its Workforce To 'Simplify' The Company
October 07, 2022
Why Biomarin Pharmaceutical Stock Hit A New 52-Week High Today
November 23, 2022
$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying
November 03, 2022
10 Analysts Have This to Say About Biomarin Pharmaceutical
October 31, 2022
Mastercard To $428? Plus This Analyst Slashes PT On Intel
October 31, 2022
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Biomarin Pharmaceutical: Q3 Earnings Insights
October 26, 2022
Recap: Biomarin Pharmaceutical Q3 Earnings
October 26, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.